These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29147685)

  • 1. Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment.
    Yu J; Zhang Y; Bomba H; Gu Z
    Bioeng Transl Med; 2016 Sep; 1(3):323-337. PubMed ID: 29147685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-Responsive Microneedle Patches for Diabetes Treatment.
    Chen G; Yu J; Gu Z
    J Diabetes Sci Technol; 2019 Jan; 13(1):41-48. PubMed ID: 29848105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.
    Wang J; Wang Z; Yu J; Kahkoska AR; Buse JB; Gu Z
    Adv Mater; 2020 Apr; 32(13):e1902004. PubMed ID: 31423670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest advances in glucose-responsive microneedle-based systems for transdermal insulin delivery.
    Martínez-Navarrete M; Pérez-López A; Guillot AJ; Cordeiro AS; Melero A; Aparicio-Blanco J
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130301. PubMed ID: 38382776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulin.
    Xia D; He H; Wang Y; Wang K; Zuo H; Gu H; Xu P; Hu Y
    Acta Biomater; 2018 Mar; 69():301-312. PubMed ID: 29421303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes.
    d'Aquino AI; Maikawa CL; Nguyen LT; Lu K; Hall IA; Jons CK; Kasse CM; Yan J; Prossnitz AN; Chang E; Baker SW; Hovgaard L; Steensgaard DB; Andersen HB; Simonsen L; Appel EA
    bioRxiv; 2023 Jul; ():. PubMed ID: 36778223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose- and pH-Responsive Supramolecular Polymer Vesicles Based on Host-Guest Interaction for Transcutaneous Delivery of Insulin.
    Lin Y; Hu W; Bai X; Ju Y; Cao C; Zou S; Tong Z; Cen C; Jiang G; Kong X
    ACS Appl Bio Mater; 2020 Sep; 3(9):6376-6383. PubMed ID: 35021768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.
    Zhao F; Wu D; Yao D; Guo R; Wang W; Dong A; Kong D; Zhang J
    Acta Biomater; 2017 Dec; 64():334-345. PubMed ID: 28974477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying emerging technologies to improve diabetes treatment.
    Jiaojiao Y; Sun C; Wei Y; Wang C; Dave B; Cao F; Liandong H
    Biomed Pharmacother; 2018 Dec; 108():1225-1236. PubMed ID: 30372824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
    Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
    Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery.
    He M; Yu P; Hu Y; Zhang J; He M; Nie C; Chu X
    ACS Appl Mater Interfaces; 2021 May; 13(17):19648-19659. PubMed ID: 33890785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimuli-Responsive Insulin Delivery Devices.
    Fuchs S; Shariati K; Ma M
    Pharm Res; 2020 Sep; 37(10):202. PubMed ID: 32968829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus.
    Domingo-Lopez DA; Lattanzi G; H J Schreiber L; Wallace EJ; Wylie R; O'Sullivan J; Dolan EB; Duffy GP
    Adv Drug Deliv Rev; 2022 Jun; 185():114280. PubMed ID: 35405298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice.
    Chai Z; Dong H; Sun X; Fan Y; Wang Y; Huang F
    Int J Biol Macromol; 2020 Sep; 159():640-647. PubMed ID: 32428589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery.
    Zhang C; Hong S; Liu MD; Yu WY; Zhang MK; Zhang L; Zeng X; Zhang XZ
    J Control Release; 2020 Apr; 320():159-167. PubMed ID: 31978443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.
    Mo R; Jiang T; Di J; Tai W; Gu Z
    Chem Soc Rev; 2014 May; 43(10):3595-629. PubMed ID: 24626293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
    Cambuli VM; Baroni MG
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical nanomotors: efficient glucose-mediated insulin release.
    Díez P; Esteban-Fernández de Ávila B; Ramírez-Herrera DE; Villalonga R; Wang J
    Nanoscale; 2017 Oct; 9(38):14307-14311. PubMed ID: 28930338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-Responsive Injectable Thermogels via Dynamic-Covalent Cross-Linking of Pluronic Micelles.
    Xian S; VandenBerg MA; Xiang Y; Yu S; Webber MJ
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4873-4885. PubMed ID: 36317822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.